Anti-SARS-CoV Nucleocapsid Protein

Severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid protein is a viral protein encoded by the N gene in SARS-CoV RNA. SARS-CoV is a member of the Betacoronavirus genus of viruses and has an approximately 79% sequence identity with SARS-CoV-2, the causative agent of COVID-19. The SARS-CoV nucleocapsid protein has a greater than 90% similarity to the SARS-CoV-2 nucleocapsid protein, and SARS-CoV-2 contains 27 T cell epitopes that are identical to SARS-CoV T cell epitopes. The SARS-CoV nucleocapsid protein packages the viral RNA into a helical ribonucleoprotein complex (RNP) that is a template for viral replication. It is integral for viral self-assembly and involved with regulation of the cell cycle. SARS-CoV is the causative agent of SARS, a primarily respiratory illness characterized by fever, cough, shortness of breath, and an approximately 10% fatality rate. Cayman's SARS-CoV Nucleocapsid Protein Polyclonal Antibody can be used for ELISA.Synonyms: SARS-CoV NP, SARS-CoV Nucleoprotein, Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein. Immunogen: Recombinant SARS-CoV nucleocapsid protein. Formulation: (Request formulation change), 100 or 200 µl of protein A-purified polyclonal antibody. Storage Buffer: 0.2 µm filtered solution in PBS. Host: Rabbit. Isotype: IgG. Applications: ELISA.